• SENSEX 72,638.70
    -429.11 (--0.59%)
  • BANKNIFTY 55,055.55
    -72.85 (--0.13%)
  • Bharti Airtel
    1,854.95 2,174.70(%)
  • Swiggy
    253.65 460.00(%)
  • Kanohar Elect.
    1,129.35 1,129.35(%)
  • HDFC Bank
    701.60 682.00(%)
  • C P C L
    1,626.80 1,677.00(%)
  • NSE
    1,736.10 1,712.00(%)
  • DLF
    652.25 489.30(%)
  • Divi's Lab.
    9,653.50 10,000.00(%)
  • Moneyview
    60.55 62.00(%)
  • United Spirits
    1,337.65 1,210.40(%)
  • Max Healthcare
    911.00 1,221.10(%)
  • One Mobikwik
    265.90 296.75(%)
  • B H E L
    446.65 229.70(%)
  • Infosys
    990.25 980.30(%)
  • Apollo Hospitals
    7,829.35 6,680.00(%)
  • Hind.Aeronautics
    4,732.40 3,479.20(%)
  • ICICI Lombard
    1,608.50 2,064.15(%)
  • Cupid
    345.05 345.05(%)
  • Rentomojo
    644.15 644.15(%)
  • Hero Motors
    172.80 179.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shilpa Medicare Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5031.0
  • ISIN : INE790G01031
1,071.20 -3 (-0.23%)
  • As on 07 Oct 2026 (EOD)

  • Today’s Low

    1,055.10

  • Today’s High

    1,086.80

  • Open

    1,072.40

  • Perv Close

    1,073.70

  • 52W Low

    259.50

  • 52W High

    1,095.00

Key Indicators

  • P/E(TTM)

    133.85

  • Mar.Cap (₹Cr.)

    20,950.72

  • Div & Yield %

    0.06

  • Book Value(₹)

    138.73

  • Debt-Equity Ratio

    -0.23

  • AGM Date

    07-Oct-2026

  • EPS

    8.01

  • P/E Ratio

    133.85

Financials Ratios

  • Debt-Equity Ratio

    0.48

  • Mar.Cap (₹Cr.)

    20,950.72

  • RONW (%)

    1.72

  • ROCE (%)

    5.16

Score Board

  • Equity (₹ in Cr.)

    19.56

  • BV (₹)

    138.70

  • Sales( ₹ in Cr.)

    597.03

  • NP (in Cr.)

    103.91

  • NP Var(%)

    12.0

  • Div%

    60.0

  • CPS (₹)

    8.10

  • EPS (₹)

    5.30

  • Traded Value (₹ in Lakhs)

    20,968.33

  • 52 Week High

    1,095.00

  • 52 Week Low

    259.50

  • Price BSE

    1072.0

  • Price NSE

    1,071.00

  • Market Capital( in Cr.)

    20,968.33

  • P/C Ratio

    131.80

  • P/E Ratio

    201.80

  • Price Vs.BV

    5.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 597.03 477.40 309.79 247.70 356.95 257.05
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 597.03 477.40 309.79 247.70 356.95 257.05
Other Income 68.74 70.69 89.12 175.32 170.50 204.49
Stock Adjustments 3.64 -6.00 -2.63 -4.08 3.18 10.26
Total Income 669.41 542.09 396.28 418.94 530.63 471.80
EXPENDITURE :            
Raw Materials 228.10 114.51 86.62 78.12 81.96 69.37
Power and Fuel Cost 18.93 17.89 18.73 18.70 17.47 12.42
Employee Cost 110.99 89.95 103.64 109.54 110.57 76.10
Other Manufacturing Expenses 21.42 12.60 15.32 18.28 22.79 16.71
Selling and Administration Expenses 94.28 99.22 49.74 60.03 106.22 55.92
Miscellaneous Expenses -17.59 47.86 17.26 18.50 -0.57 3.43
Employee Benefit Expenses 110.99 89.95 103.64 109.54 110.57 76.10
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 456.13 382.03 291.31 303.17 338.44 233.95
Operating Profit 213.28 160.06 104.96 115.78 192.18 237.86
Interest 10.04 5.87 17.26 20.83 9.05 6.07
Gross Profit 203.24 154.19 87.70 94.95 183.13 231.79
Depreciation 55.11 48.86 49.61 46.55 34.82 22.28
Profit Before Tax 148.13 105.33 38.09 48.40 148.31 209.51
Current Tax 10.97 47.08 11.29 -8.37 4.80 15.78
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.18 -9.65 -0.13 -0.43 2.53 9.34
Reported Net Profit 132.98 67.90 26.94 57.19 140.99 184.39
Extraordinary Items 29.07 -24.67 -6.93 -15.86 8.23 46.40
Adjusted Net Profit 103.91 92.57 33.87 73.05 132.76 137.99
Adjustment below Net Profit -56.95 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1,375.17 1,307.27 1,332.11 1,284.46 1,152.44 968.05
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 9.78 0.00 0.00 9.55 8.97 0.00
P & L Balance carried down 1,441.42 1,375.17 1,359.05 1,332.11 1,284.46 1,152.44
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 60.00 100.00 0.00 0.00 110.00 110.00
Dividend Per Share(Rs) 0.60 1.00 0.00 0.00 1.10 1.10
Earnings Per Share-Unit Curr 6.80 6.94 3.10 6.59 16.24 22.62
Earnings Per Share(Adj)-Unit Curr 6.80 3.47 1.55 3.30 8.12 11.31
Book Value 138.72 270.65 246.85 243.96 237.97 200.89
Book Value(Adj)-Unit Curr 138.72 135.33 123.43 121.99 118.99 100.45

Shareholding Pattern

  • Promoter Group

    40.13%

  • Public Share Holding

    59.87%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 78,496,648 40.13 78,496,648 21
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 78,496,648 40.13 78,496,648 21
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 1,004 0.00 1,004 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 23,683,565 12.11 23,683,565 154
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 5,015,542 2.56 5,015,542 1
Mutual Funds / UTI 8,220,882 4.20 8,220,882 13
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,925,957 1.50 2,925,957 20
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 39,846,950 20.37 39,846,950 190
2] Non Institution
Bodies Corporate 15,232,452 7.79 15,232,452 1,101
Clearing Members 121 0.00 121 2
Directors of their Relatives 62,150 0.03 62,150 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 5,358,282 2.74 5,358,282 2,298
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,705,322 0.87 1,705,322 1,879
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 21,274,266 10.88 21,274,266 23
Individuals holding nominal share capital up to Rs. 1 lakh 32,968,947 16.86 32,859,197 81,955
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 119,004 0.06 119,004 5
Others 517,674 0.26 517,674 1
Sub Total 77,238,218 39.49 77,128,468 87,266
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 195,581,816 100.00 195,472,066 87,477

Company Background

Shilpa Medicare LtdPharmaceuticals - Indian - Formulations

  • Shilpa Medicare Ltd
  • BSE Code : 5031.0
  • ISIN : INE790G01031

  • Incorporation Year

    1987

  • Registered Office

    #12-6-214/A1
    Hyderabad Road, Raichur,
    Karnataka-584135

  • Telephone

    91-8532-238704

  • FAX

    91-8532238876

  • Chairman

    Omprakash Inani

  • Managing Director

  • Company Secretary

    Ritu Tiwary

  • Auditor

    B N P S and Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Shilpa Medicare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shilpa Medicare 1,072.10 635.18 597.03 114.79 4.78
Abbott India 26,087.15 7,217.19 6,929.05 34.33 43.78
Astrazeneca Phar 5,918.55 2,304.07 2,275.58 87.23 27.86
Glaxosmi. Pharma 2,633.25 3,932.76 3,790.20 42.06 58.17
Novartis India 2,011.30 393.10 354.33 50.79 15.94
Cipla 1,329.50 20,102.60 18,979.95 34.94 13.88
Bliss GVS Pharma 677.95 773.53 729.81 63.01 12.51
Fermenta Biotec. 566.40 474.15 450.25 26.44 18.77
Amrutanjan Healt 521.45 520.13 502.55 27.93 24.16
Guj. Themis Bio. 379.75 168.25 165.82 101.54 18.05
Ambalal Sarabhai 40.07 19.52 3.94 74.20 6.77